GRAIL Inc. (GRAL) vs MiniMed Group, Inc. Common Stock (MMED)
A side-by-side comparison of GRAIL Inc. and MiniMed Group, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GRAL
GRAIL Inc.
$137.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MMED
MiniMed Group, Inc. Common Stock
$19.64HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GRAL vs MMED
growth of $100 · dividends reinvested · last 1yGRAL +206.7% (+206.7%/yr)MMED +9.0% (+9.0%/yr)GRAL compounded faster over this window
GRAL MMED
GRAL vs MMED: by the numbers
- •GRAL is the larger company ($5.89B vs $5.52B market cap).
- •Both run net losses; MMED's is the smaller (-10.21% vs -236.95% net margin).
Metrics side by side
Valuation
| Metric | GRAL | MMED |
|---|---|---|
| Forward P/E | N/A | 29.17 |
| P/S ratio | 35.65 | 1.71 |
| P/B ratio | 2.32 | 1.52 |
| EV / EBITDA | N/A | 30.67 |
Profitability
| Metric | GRAL | MMED |
|---|---|---|
| Gross margin | -42.52% | 53.85% |
| Operating margin | -362.95% | 0.53% |
| Net margin | -236.95% | -10.21% |
| ROE | -15.40% | -9.09% |
| ROIC | -20.26% | 0.43% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.